HUP0200173A3 - Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne - Google Patents
Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acneInfo
- Publication number
- HUP0200173A3 HUP0200173A3 HU0200173A HUP0200173A HUP0200173A3 HU P0200173 A3 HUP0200173 A3 HU P0200173A3 HU 0200173 A HU0200173 A HU 0200173A HU P0200173 A HUP0200173 A HU P0200173A HU P0200173 A3 HUP0200173 A3 HU P0200173A3
- Authority
- HU
- Hungary
- Prior art keywords
- progestogen
- acne
- estrogen
- preventing
- pharmaceutical compositions
- Prior art date
Links
- GEONECATAKDDLT-JDSZYESASA-N (8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol;[(8r,9s,10r,13s,14s,17r)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 GEONECATAKDDLT-JDSZYESASA-N 0.000 title 1
- 208000002874 Acne Vulgaris Diseases 0.000 title 1
- 206010000496 acne Diseases 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000583 progesterone congener Substances 0.000 title 1
- 230000009759 skin aging Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26176501P | 2001-01-16 | 2001-01-16 | |
| US31296101P | 2001-08-16 | 2001-08-16 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0200173D0 HU0200173D0 (en) | 2002-03-28 |
| HUP0200173A2 HUP0200173A2 (en) | 2002-10-28 |
| HUP0200173A3 true HUP0200173A3 (en) | 2004-03-29 |
Family
ID=26948819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0200173A HUP0200173A3 (en) | 2001-01-16 | 2002-01-15 | Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20020197286A1 (hu) |
| EP (1) | EP1230952A3 (hu) |
| JP (1) | JP2002212078A (hu) |
| KR (1) | KR20020061536A (hu) |
| CN (1) | CN1174751C (hu) |
| AU (1) | AU1015802A (hu) |
| CA (1) | CA2367186A1 (hu) |
| HK (1) | HK1047713A1 (hu) |
| HU (1) | HUP0200173A3 (hu) |
| IL (1) | IL147558A0 (hu) |
| NZ (1) | NZ516465A (hu) |
| PL (1) | PL351737A1 (hu) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060010010A1 (en) * | 2004-07-12 | 2006-01-12 | Benjamin Wiegand | Method for recommending an acne treatment/prevention program |
| US20100261985A1 (en) * | 2006-03-31 | 2010-10-14 | Koninklijke Philips Electronics, N.V. | Method and apparatus for determining hydration levels from skin turgor |
| US20100017750A1 (en) * | 2008-07-16 | 2010-01-21 | Avner Rosenberg | User interface |
| JP6285866B2 (ja) | 2011-11-23 | 2018-02-28 | セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． | 天然複合ホルモン補充製剤および療法 |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| KR20170005819A (ko) | 2014-05-22 | 2017-01-16 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 천연 복합 호르몬 대체 제형 및 요법 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1309967A (zh) * | 2000-02-23 | 2001-08-29 | 张红黎 | 治疗粉刺的护肤膏 |
-
2001
- 2001-12-05 US US10/007,158 patent/US20020197286A1/en not_active Abandoned
-
2002
- 2002-01-07 NZ NZ516465A patent/NZ516465A/en unknown
- 2002-01-09 CA CA002367186A patent/CA2367186A1/en not_active Abandoned
- 2002-01-10 EP EP02250159A patent/EP1230952A3/en not_active Withdrawn
- 2002-01-10 IL IL14755802A patent/IL147558A0/xx unknown
- 2002-01-14 AU AU10158/02A patent/AU1015802A/en not_active Abandoned
- 2002-01-15 HU HU0200173A patent/HUP0200173A3/hu unknown
- 2002-01-15 KR KR1020020002290A patent/KR20020061536A/ko not_active Application Discontinuation
- 2002-01-16 JP JP2002007894A patent/JP2002212078A/ja active Pending
- 2002-01-16 CN CNB021018677A patent/CN1174751C/zh not_active Expired - Fee Related
- 2002-01-16 PL PL02351737A patent/PL351737A1/xx not_active Application Discontinuation
-
2003
- 2003-01-03 HK HK03100046.1A patent/HK1047713A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL147558A0 (en) | 2002-08-14 |
| CN1174751C (zh) | 2004-11-10 |
| JP2002212078A (ja) | 2002-07-31 |
| US20020197286A1 (en) | 2002-12-26 |
| KR20020061536A (ko) | 2002-07-24 |
| AU1015802A (en) | 2002-07-18 |
| HUP0200173A2 (en) | 2002-10-28 |
| EP1230952A3 (en) | 2003-05-07 |
| HK1047713A1 (zh) | 2003-03-07 |
| NZ516465A (en) | 2003-08-29 |
| EP1230952A2 (en) | 2002-08-14 |
| HU0200173D0 (en) | 2002-03-28 |
| PL351737A1 (en) | 2002-07-29 |
| CN1380063A (zh) | 2002-11-20 |
| CA2367186A1 (en) | 2002-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200173A3 (en) | Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne | |
| HUP0104718A3 (en) | Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions | |
| HUP0204291A3 (en) | Use of composition containing estrogen and drospirenone for hormone replacement therapy | |
| ZA200605224B (en) | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions | |
| WO1998027929A3 (de) | Therapeutische gestagene zur behandlung von premenstrual dysphoric disorder | |
| HUP0302093A3 (en) | Use of conjugated estrogens and medroxyprogesterone acetate for producing pharmaceutical compositions for hormone replacement therapy | |
| GEP20053586B (en) | Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same | |
| HUP0401935A3 (en) | Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof | |
| HUP0202500A3 (en) | Use of a pharmaceutical combination of ethinylestradiol and drospirenone for producing pharmaceutical compositions having contraceptive activity | |
| HUP0004133A3 (en) | Combined use of progestin and polycarboxilic acid for the preparation of pharmaceutical compositions for controlled bleeding | |
| HK1048269A1 (en) | The use of non-oral androgenic steroids in the manufacture of medicine for improving elevated sex hormone binding globulin levels | |
| PL345955A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL | |
| IL161105A0 (en) | Estrogen/gestagen combination preparation and application thereof | |
| WO2002058706A3 (en) | Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy | |
| AU1460801A (en) | Cholesterol reducing sterol compositions, preparation and method of use | |
| ZA200700483B (en) | Process for the preparation 2-substituted-derivatives of estrone and estradiol | |
| HK1050472B (zh) | 基於醋酸諾美孕酮和雌激素的激素組合物及其用途 | |
| HUP0300626A3 (en) | Use of progestogen and mifepristone for preparation of anticancer pharmaceutical compositions | |
| PL332610A1 (en) | Hormonal preparation consisting of an oestrogen compound and of a progesterone compound | |
| AU1463601A (en) | Cholesterol reducing stanol compositions, preparation and method of use | |
| HUP0303020A3 (en) | Androgenic 7-substituted 11-halogen steroids, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP0203443A2 (hu) | Új fogamzásgátló gyógyszer és eljárás előállítására | |
| AU2001278738A1 (en) | Medicinal compositions for preventing and treating cancer | |
| WO2002022645A3 (en) | Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity | |
| WO2000067708A3 (en) | Oral steroidal hormone compositions and methods of use |